Cite

HARVARD Citation

    Qu, M. et al. (n.d.). 92 Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-COMET. Radiotherapy and oncology. pp. S41-S42. [Online]. 
  
Back to record